The 3rd JCA-AACR Special Joint Conference
Schedule Download
Instructions for Oral presenters（32KB）
Instructions for Poster presenters（69KB）
The Latest Advances in Liver Cancer Research:
From Basic Science to Therapeutics
March 1st(tue.)-3rd(Thu), 2011
Tokyo Bay Maihama Hotel Club Resort
( former"TOKYO BAY HOTEL TOKYU")
1-7, Maihama, Urayasu-shi, Chiba 279-0031
TEL: 047-355-2411
http://www.tbm-clubresort.jp/eng/
※We closed the abstract submission
※We closed the online registration
【Travel grant for foreign abstract registrants】
※We closed the travel grant application
- JCA committee member:(http://www.jca.gr.jp/)
- Kunitada Shimotohno (Chiba Institute of Technology)
Michiie Sakamoto (Keio Univ.)
Shuichi Kaneko (Kanazawa Univ.) - AACR committee member:(http://www.aacr.org/)
- Scott Lowe (Cold Spring Harbor Laboratory)
Curtis C. Harris (National Cancer Institute)
Scott L. Friedman (Mount Sinai School of Medicines)
Program (tentative)
Mar. 1st
| Session | chair person | Speaker(tentative) | Title |
|---|---|---|---|
| Keynote Lecture | Dr. Lowe Dr. Sakamoto |
Dr. Michiie Sakamoto (Keio Univ) |
Molecular Pathology of Multistage Hepatocarcinogenesis |
| Dr. Scott Lowe (Cold Spring Harbor Lab) |
Integrated Approaches To Cancer Gene Discovery Using Mouse Models And RNAi |
Mar. 2nd
| Session | chair person | Speaker(tentative) | Title |
|---|---|---|---|
| Pathogenic agents and Molecular epidemiology | Dr. Ploss Dr. Shimotohno |
Dr. Makoto Hijikata (Kyoto Univ) |
Novel targets for anti HCV drugs preventing infectious virus particle production |
| Dr.Alexander Ploss (The Rockfeller Univ. NY) |
Analysis of Hepatitis C virus infection and pathogenesis in small animal models | ||
| Dr. Yasuhito Tanaka (Nagoya City Univ.) |
Direct cytopathic effects by hepatitis B virus | ||
| Dr. Naoki Hiramatsu (Osaka Univ.) |
Efficacy of peg-IFN/Ribavirin combination therapy in hepatitis C | ||
| Preneoplastic liver injury | Dr. Friedman Dr. Kaneko |
Dr. Shuichi Kaneko (Kanazawa Univ) |
Gene Expression Profiles of Chronic Viral Hepatitis |
| Dr. Hiroyuki Marusawa (Kyoto Univ) |
Inflammation in the pathogenesis of genetic alteration leading to liver carcinogenesis | ||
| Dr. Lars Zender (Hannover Medical School, Germany) |
Senescence Surveillance in Hepatocellular Carcinoma | ||
| Lunch & poster view | |||
| Poster presentation | |||
| Preneoplastic liver injury | Dr. Friedman Dr. Kaneko |
Dr. Scott Friedman (Mount Sinai School of Medicine, NY) |
Permissive effects of fibrosis and the microenvironment on HCC development |
| Dr. Koichi Matsuzaki (Kansai Medical Univ) |
Revercible phosphorylated smad3 singaling between tumor-suppression and fibro-carcinogenesis in chronic hepatitis C | ||
| Molecular carcinogenesis | Dr. Harris Dr. Aburatani |
Dr. Curtis C Harris (National Cancer Institute, MD) |
p53, microRNAs and senescence in human carcinogenesis |
| Dr. Kazuhiko Koike (Tokyo Univ) |
Hepatocarcinogenesis in HCV infection | ||
| Dr. Yae Kanai (National Cancer Center) |
DNA methylation alterations during multistage hepatocarcinogenesis |
||
| Meet-the Expert Evening(all participants) | |||
Mar. 3rd
| Session | chair person | Speaker(tentative) | Title |
|---|---|---|---|
| Molecular carcinogenesis | Dr. Harris Dr. Aburatani |
Dr. Tatsuhiro Shibata (National Cancer Center) |
Decoding of virus-associated liver cancer geuome |
| Dr. Hiroyuki Aburatani (Tokyo Univ) |
Integrated genomic analysis of liver cancer | ||
| Molecular diagnosis | Dr. Villanueva Dr. Sakamoto |
Dr. Shuji Terai (Yamaguchi Univ) |
HHM (Human homoglue of Maid) : an important regulator to control hepatocarcinogenesis and liver fibrosis |
| Dr. Augusto Villanueva (BCLC, Spain) |
Molecular pathogenesis of HCC: preliminary steps in personalized medicine | ||
| Dr. Goshi Shiota (Tottori Univ.) |
Development of highly sensitive assay of serum hTERT mRNA for diagnosis of hepatocellular carcinoma | ||
| Metastasis and stem cells | Dr. Gouon-Evans Dr. S.Tanaka |
Dr. Tetsuhiro Chiba (Chiba Univ.) |
Regulation of liver cancer stem cell maintenance by polycomb group proteins |
| Dr. Valerie Gouon-Evans (Mount Sinai School of Medicine, NY) |
The endothelial cell niche controls the development of hepatic progenitors | ||
| Lunch & Poster view | |||
| Metastasis and stem cells | Dr. Gouon-Evans Dr. S.Tanaka |
Dr. Shinji Tanaka (Tokyo Medical and Dental) |
Microenvironment and stemness potentials in hepatocellular carcinoma |
| Molecular targeted therapy | Dr. Wang Dr. Ohdan |
Dr. Taro Yamashita (Kanazawa Univ.) |
Targeting distinct cancer stem cells defined by HCC subtypes |
| Dr. Xin Wei Wang (National Cancer Institute, MD) |
Integrative analysis of liver cancer omic data: linking genomics and phenomics to identify novel molecular targets | ||
| Dr. David Bumcrot(Alnylam Pharmaceuticals Inc, MA) | Development of ALN-VSP: an RNAi therapeutic for solid tumors | ||
| Dr. Hideki Ohdan (Hiroshima Univ.) |
Adoptive immunotherapy for inducing anti-HCC and anti-HCV activity after liver transplantation | ||
| Closing remark | |||
Meet-the Expert Evening
March 2nd(Wed), 17:30-19:00
Poster Presentation
March 2nd(Wed), 12:50-14:20